Tarsus Pharmaceuticals Inc. (TARS)
Market Closed
10 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
61. 27
-0.28
-0.4549%
Pre Market
$
+5.23 +8.536% 66. 50
2.6B Market Cap
- P/E Ratio
- Div Yield
262,525 Volume
-4.18 Eps
$ 61.55
Previous Close Investors:
Want to track TARS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
TARS Earnings Reports FAQ
What is the earnings per share (EPS) for TARS?
The current EPS is -4.18.
What is the company's earnings growth rate?
Tarsus Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Tarsus Pharmaceuticals Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Tarsus Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for TARS at this time, as Tarsus Pharmaceuticals Inc has no recent EPS data to calculate it.
